U.S. Electrical Stock News

NasdaqGS:CERT
NasdaqGS:CERTHealthcare Services

Certara (CERT) Stock Price Faces Loss Pressure Despite Software Gains

Certara entered this earnings report with the stock up strongly over the past three months, then gave back 4.7% to close at US$7.80 after the Q2 release. The selloff contrasts with the core thesis that this is a steadily improving software driven drug development platform. The headline this quarter is not revenue growth. It is the tension between healthy profitability on an adjusted basis and continuing losses under generally accepted accounting principles. Certara delivered US$93.3m in...
NYSE:PUMP
NYSE:PUMPEnergy Services

Is ProPetro (PUMP) Turning Stable Per‑Share Losses Into a Strategic Shift in Its Business Mix?

ProPetro Holding Corp. has reported past half-year results for the period ended June 30, 2026, posting a net loss of US$8.11 million, slightly higher than the US$7.16 million loss in the same period a year earlier, with basic and diluted losses per share unchanged at US$0.07. The stability in per-share losses despite a larger overall net loss raises questions about how shifts in share count, cost structure, or mix of operations may be affecting shareholder outcomes. Against this backdrop of...
NYSE:MD
NYSE:MDHealthcare

Pediatrix Medical Group (MD) Stock Slides As Volume Weakness Clouds EPS Gain

Pediatrix Medical Group dropped almost 6% today, yet the headline from this quarter is not a collapse in profit. The stock came into the print already soft over the past month, then sold off again even as Q2 basic EPS reached about US$0.50 and revenue sat near US$488 million. The market is fixated on near term worries around pricing tailwinds and volumes. The numbers tell a more nuanced story of a physician services business wrestling with sentiment while margins and earnings trend in a...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Rhythm Pharmaceuticals (RYTM) Stock Rises As HO Demand Meets Loss Pressure

Rhythm Pharmaceuticals stock closed up 2.9% at US$105.78, a sharp intraday vote of confidence after a choppy month that left the shares down about 7% over 30 days. The move came as investors digested a Q2 report that paired rapid revenue expansion with continued losses, a familiar trade off in high growth biotech. The headline this quarter is clear. Global net product sales reached US$71.3 million, powered by early demand for IMCIVREE in acquired hypothalamic obesity, while the company still...
NYSE:BRCC
NYSE:BRCCFood

Black Rifle Coffee (BRC) Stock Faces Margin Questions Despite Free Cash Flow Turnaround

BRC stock walked into this earnings print treading water. The share price has gone nowhere on the day at about US$1.05, even after a year that left holders facing double digit declines. The business story looks very different. Black Rifle Coffee Company just put up roughly US$107 million of Q2 revenue and turned in positive free cash flow of about US$5.4 million. Gross margin edged into the mid 30s and adjusted EBITDA reached about US$6.3 million. For a company still working through losses,...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Sterling Infrastructure (STRL) Stock Pullback Follows AI Backlog Fueled Growth

Sterling Infrastructure stock just dropped 11% to about US$542 after a hot run into earnings, yet the quarter was anything but cold. The company posted Q2 revenue of US$1.17b and basic earnings per share of US$5.08, powered by a surge in high margin E Infrastructure projects. That clash between a sharp price pullback and robust reported growth sets up a clear time horizon choice for you: focus on today’s volatility or on a business now carrying a US$4.3b signed backlog and multi year project...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

How Exelon’s Q2 Results, Dividend and Grid Investments Could Impact Exelon (EXC) Investors

Exelon Corporation recently reported its second-quarter 2026 results, with revenue rising to US$5,967 million and net income of US$396 million, while the board also declared a regular quarterly dividend of US$0.42 per share payable in September. Alongside reaffirming full-year earnings guidance, management underscored ongoing investments in battery storage, transmission expansion, and grid reliability projects aimed at addressing capacity shortfalls and supporting long-term service...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

AMD (AMD) Stock Could Be 30% Overvalued Despite Fresh AI Partnership News

Advanced Micro Devices stock has delivered a very strong run over the past few years, while the current valuation signals are pulling in different directions. The Discounted Cash Flow (DCF) intrinsic value estimate points to a premium to today’s price, while earnings based multiples suggest the stock may still be on the cheap side. Over the last 5 years, Advanced Micro Devices has returned about 3.9x, which sets a high bar for any further upside to be justified by fundamentals. Large AI...
NYSE:PII
NYSE:PIILeisure

Is Polaris (PII) Overvalued As Its 2027 Off Road Lineup Draws Investor Interest?

Polaris (PII) has just put its 2027 Off Road lineup in front of riders and investors, headlined by the RZR Pro R Boost with 275 horsepower and a reworked XPEDITION featuring a pneumatic CVT. See our latest analysis for Polaris. Polaris shares have picked up momentum around the new Off Road lineup and recent earnings update, with a 1 month share price return of 16.86% and a 1 year total shareholder return of 45.50%, although the 3 and 5 year total shareholder returns remain sharply...
NYSE:INSP
NYSE:INSPMedical Equipment

Inspire Medical Systems (INSP) Stock Jumps As Profit Returns Through Revenue Slip

Inspire Medical Systems stunned the market today. The stock jumped about 23% to US$64.14 after earnings, extending strong recent gains, even though Q2 revenue sat at US$200.6m and slipped against last year as coding and reimbursement issues weighed on implant volumes. The real story sits on a longer clock. Inspire Medical Systems turned a small quarterly profit of roughly US$0.01 per share and delivered positive operating cash flow while revenue pressure remained, then paired that with a...
NYSE:CTOS
NYSE:CTOSTrade Distributors

Custom Truck One Source (CTOS) Stock Gains On Record Revenue And Profit Return

Custom Truck One Source stock closed up 3.7% at US$11.02, which signals a warm reception to earnings on the day. The immediate story is simple. Investors liked what they saw. The bigger story sits beyond today’s move. Custom Truck One Source just posted record quarterly revenue of US$563.4m and turned a quarterly profit, while management lifted full year revenue and adjusted earnings guidance. For a capital intensive specialty rental and equipment player, that combination of top line strength...
NYSE:ITGR
NYSE:ITGRMedical Equipment

Integer Holdings (ITGR) Stock Margins Improve As Debt Questions Persist

Integer Holdings stock barely budged today, up about 0.5% and extending a steady three month climb, even though the latest quarter quietly rewired the earnings story. The medical device manufacturer turned in Q2 basic earnings per share of about US$0.69 on revenue of roughly US$464 million. The real headline sits in the trailing 12 month picture, where net margin stands at 7% and earnings from continuing operations total about US$128 million. For anyone thinking beyond this week’s chart, the...
NYSE:TEL
NYSE:TELElectronic

How Investors May Respond To TE Connectivity (TEL) Earnings Beat And Completion Of Long-Term Buyback

In the past quarter, TE Connectivity plc reported higher sales of US$5,160 million and increased net income of US$748 million, while also completing a long-running share repurchase program totaling 274,232,749 shares since its 2007 authorization. The combination of stronger earnings per share and the long-term reduction in share count underscores how TE Connectivity has paired profit growth with sustained capital returns to shareholders. With this backdrop of stronger quarterly earnings and...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Does Opendoor’s 42.6% Revenue Drop Without Estimate Cuts Reshape The Bull Case For OPEN?

Earlier this week, Opendoor Technologies (NASDAQ: OPEN) reported quarterly results after market close, with revenue expected to show a 42.6% year-on-year decline versus growth in the same period last year. Analysts have largely maintained their earnings estimates ahead of this release, suggesting the market is watching how Opendoor manages a sharply weaker top line without a major reset in expectations. Next, we'll explore how the anticipated revenue drop shapes Opendoor's existing...
NYSE:JELD
NYSE:JELDBuilding

JELD WEN (JELD) Stock Rallies As Margin Gains Meet Leverage Risk

JELD-WEN Holding stock jumped about 26% today, a sharp swing for a company that has been trading under the weight of deep losses and balance sheet stress. The move reflects relief more than euphoria. The headline is that JELD-WEN finally put up a cleaner quarter, with Q2 revenue of about US$818 million and adjusted EBITDA of US$42 million, while still reporting a net loss. Investors are reacting to signs that the margin story is starting to improve, even though the profit and leverage issues...
NYSE:LDOS
NYSE:LDOSProfessional Services

Leidos (LDOS) Stock Jumps As Cash Flow Reshapes The Story

Leidos Holdings entered this quarter with a value profile and a flat three month share price, then surprised the market with a 10% jump to about US$130.60 once investors saw the numbers. The company delivered Basic EPS of US$2.81 on revenue of US$4.56b, alongside record operating cash flow, which gave investors in this defense and government technology contractor specific results to reprice. The stock now reflects a sudden reset of expectations that were not fully captured in the modest...
NYSE:WHR
NYSE:WHRConsumer Durables

Whirlpool (WHR) Stock Rebounds As Thin Margins Keep Pressure On

Whirlpool stock ripped higher, jumping 13.8% to US$44.62, as investors grabbed for a quick rebound story in a company that has spent the last year grinding through profit pressure and balance sheet fixes. The headline this quarter is margin, not sales. Management delivered a slim 1.8% ongoing operating margin on about US$3.5b of Q2 revenue and still expects only about 4% for the full year. For a global appliance manufacturer with heavy debt and rising interest costs, that kind of margin...
NasdaqGS:OZK
NasdaqGS:OZKBanks

Bank OZK (OZK) Draws Valuation Focus, Is The Stock Fairly Valued?

Bank OZK (OZK) has drawn fresh attention after its recent share price moved around current valuations, with the stock closing at $52.24. Investors are examining how this development relates to the bank’s broader fundamentals. See our latest analysis for Bank OZK. Over the past year, Bank OZK has combined a 11.05% year to date share price return with a 11.45% 1 year total shareholder return, while its 3 year and 5 year total shareholder returns of 35.41% and 45.80% hint at gradually building...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Alignment Healthcare (ALHC) Beat Earnings And Raised Guidance, Is The Upside Still Worth The Risk?

Why Alignment Healthcare’s latest earnings matter for investors Alignment Healthcare (ALHC) has drawn fresh attention after reporting second quarter 2026 results and updating its revenue outlook, putting recent stock volatility and ongoing legal investigations into sharper focus for investors. See our latest analysis for Alignment Healthcare. Despite stronger recent earnings and higher guidance, Alignment Healthcare’s share price has come under heavy pressure, with a 30 day share price return...
NYSE:DD
NYSE:DDIndustrials

DuPont (DD) Stock Faces Valuation Doubts Despite Stronger Margins And Cash Flow

DuPont de Nemours stock edged up about 1% in regular trading after its latest earnings, a muted move for a company that just lifted guidance and put fresh cash flow on the table. Short term traders are reacting to a neat quarter built on 4% organic sales growth and adjusted earnings per share of US$1.88. Long term investors will likely care more about what sits behind that print. The core industrial and healthcare franchises are now generating higher operating margins and strong free cash...
NYSE:EG
NYSE:EGInsurance

Everest Group (EG) Stock Ignores Strong Underwriting As Revenue Retreats

Everest Group stock barely flinched after earnings, slipping about 0.8% to roughly US$369 and leaving the 7 day move only modestly in the red. That calm surface hides a stronger story. The insurer just posted quarterly basic earnings per share of US$14.23 on US$4.0b in revenue with a combined ratio of 92%. For a property and casualty player, that underwriting result is the headline. The market looks more hesitant than impressed, which raises a clear question for investors about whether short...
NasdaqGS:PFG
NasdaqGS:PFGInsurance

Principal Financial Group (PFG) Q2 Earnings Put Its Fair Value Narrative Back In Focus

Why Principal Financial Group Stock Is Back on Investor Radars Principal Financial Group (PFG) has drawn fresh attention after reporting second quarter 2026 results that showed higher revenue, broadly steady net income, and slightly higher earnings per share compared with a year earlier. See our latest analysis for Principal Financial Group. Principal Financial Group’s share price has gained 3.9% over the past month and 28.9% year to date, while the 1 year total shareholder return of 56.9%...
NYSE:ETR
NYSE:ETRElectric Utilities

UnitedHealth Stock And Other Dividend Growth Names Worth Watching

Record highs for the S&P 500 and Dow, softer Treasury yields and sharp moves in oil and tech are reshaping where dividend growth stocks may fit in a portfolio. With corporate earnings surprising to the upside and AI linked tech stocks back in focus, investors looking for growing income streams now have a fresh backdrop to consider. This article walks through 3 dividend growth stocks from our screener that appear closely tied to these market drivers. The goal is to help you decide whether...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Should Zimmer Biomet’s Solid Hip and Knee Demand Amid Muted Growth Require Action From ZBH Investors?

Zimmer Biomet’s recently reported second-quarter results highlighted ongoing strength in its hip triple-play and knee portfolios, even as analysts reassessed the company’s muted revenue growth and modest 4.2% return on capital in light of its long operating history and global scale. The key tension now is between solid procedural demand in core orthopedics and growing concern that management has limited avenues for highly profitable expansion. Next, we’ll explore how this mix of resilient...